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Editorial
The role of diet and nutrition on mental health and wellbeing
Mental, neurological and substance-use disorders presently represent the greatest global bur-
den of disease. Likewise, depression and other psychopathologies are elevated risk
comorbidities of other health hazards, such as obesity. Nutrition has been implicated in
behaviour, mood and in the pathology and treatment of mental illness. In this brief editorial,
we aim to set the scale of the problem in context and overview advances and recent evidence
linking nutrition to psychological outcomes. The purpose of the 2016 Nutrition Society
Winter Meeting, ‘Diet, nutrition and mental health and wellbeing’ was to review where
the evidence is strong, where there are unmet needs for research and to draw together the
communities working in this area to share their ﬁndings. The papers presented demonstrated
clear advancements that are being made in this ﬁeld. The meeting illustrated compelling sup-
port for nutrition as a modiﬁable risk factor. The present research in the ﬁeld and evidence
presented at the 2016 Nutrition Society Winter Meeting lead us to postulate that even inter-
ventions with relatively modest effect sizes may plausibly and signiﬁcantly curtail the disease
burden of mental and neurological disease by food- and nutrient-based approaches.
Diet: Nutrition: Mental health: Cognition: Wellbeing
Mental, neurological and substance-use disorders are the
leading global burden of disease
It has recently been estimated that mental, neurological and
substance-use disorders (i.e. schizophrenia, depression, epi-
lepsy, dementia, alcohol dependence) account for 13 % of
the global burden of disease placing mental illness as the
greatest burden, exceeding both CVD and cancer(1). While
sobering, these ﬁgures are perhaps unsurprising since there
is now one new case of dementia diagnosed every 4 s, or
7·7 million cases per year(2). More than 300 million people
are now living with depression, an increase of more than
18 % between 2005 and 2015. By 2020, it is estimated that
between 15 and 30 million people will attempt suicide and
approximately 1·5 million per year will die by suicide each
year(3). Alcohol and illicit drug use account for over 5·1 %
of global burden of disease and worldwide, 3·3 million
deaths every year result from harmful use of alcohol(4).
From social and economic perspectives, our health sys-
tems are not prepared for this extraordinary global bur-
den. Lobbying for legislative and community-level
interventions has begun and a World Health Assembly
resolution passed in May 2013 has called for a compre-
hensive, coordinated response to mental disorders at
country level. While treatment intervention is urgently
needed, health improvements and cost savings are achiev-
able by providing targeted, evidence-based, disease pre-
vention programmes that reduce modiﬁable risk factors.
Diet and nutrition as preventative measures
Nutritional psychiatry is a new, rapidly emerging ﬁeld
of nutrition and mental health and is one such avenue
of prevention. Over the past decade, there has been a
steady increase in epidemiological studies investigating
the relationships between dietary patterns and mental
states. Both cross-sectional and longitudinal studies
have shown that the more one eats a Western or highly
processed diet, the more one is at risk for developing
psychiatric symptoms, such as depression and anxiety.
Conversely, the more one eats a Mediterranean-style
diet, the more one is protected from developing a men-
tal disorder(5). In terms of direction of causality, in sev-
eral studies, the dietary pattern has been shown to
precede the onset of psychiatric symptoms. One rando-
mised controlled trial published this year in BMC
Medicine demonstrated quite striking effects of a
3-month dietary intervention on moderate-to-severe
depression, with a signiﬁcantly greater improvement in
the dietary intervention group and remission achieved
in 32 % of this group(6).
The consequences of a poor diet also impact on a fur-
ther global health hazard: obesity. Alzheimer’s disease
and depression are comorbidities of obesity, leading to
the theory that vascular impairments may have a role
in the development of dementia and psychiatric patholo-
gies. As a result of these observations, Alzheimer’s dis-
ease and other dementias are now being thought of as
potentially preventable diseases. In a 27-year longitu-
dinal study, obesity in mid-life was shown to double
the risk of developing dementia at a later age(7); more-
over while cognitive deﬁcits have been associated with
glycaemic regulation in diabetes, only in the recent
years has it been observed that cognitive deﬁcits exist
in young healthy, normal weight individuals with poor
glucoregulation, again exemplifying the need for early,
rather than later life, preventative nutrition measures.
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In addition to whole dietary and intervention strategies,
signiﬁcant advances have also been made in the study of
nutraceuticals. Previous research in this area has been
badged as ‘complementary medicine’ and scientiﬁc rigor
of research investigating these interventions has not
always matched that of pharmaceutical research.
However, good converging evidence from high-quality
randomised controlled trials is now demonstrating effect-
iveness of a large number of nutraceuticals as mood-
modifying and cognitive-enhancing agents in both clinical
and healthy populations (a comprehensive review is
beyond the scope of the editorial). Recent mechanistic
work has indicated plausible, modiﬁable, cognition-
related targets for nutraceuticals, including processes
involved with systemic and central vascular function,
inﬂammation, metabolism, central activation, improved
neural efﬁciency and angiogenesis. The quantity of good,
well-controlled clinical trials examining nutraceutical
interventions has meant that nutraceuticals are increas-
ingly being used and prescribed in psychiatric practice.
A further new avenue in nutritional psychiatry has
been the eruption of research targeting the modulation
of the gut microbiota (through probiotic and prebiotic
foods and supplements) as a novel therapy for the treat-
ment of various neuropsychiatric conditions. The bidirec-
tional communication between the gut microbiota and
the brain has been shown to inﬂuence neurotransmission
and the behaviour that is often associated with neuro-
psychiatric conditions, and likewise the microbiome has
been associated with multiple systemic pathologies and
obesity(8). However, this research is still in its infancy
with an urgent need for prospective studies.
The mechanisms of nutritional impact on the brain are
likely to be many, complex and compound. However,
recent research has focused on adult hippocampal neuro-
genesis. The hippocampus is a brain region associated
with learning, memory and mood and is one of two struc-
tures in the adult brain where neurogenesis persists. The
degree of neurogenesis in the hippocampus has been linked
directly to cognition andmood, thusmodulation of hippo-
campal neurogenesis by diet has recently emerged as a pos-
sible mechanism by which nutrition may impact on brain
plasticity, function and mental health(9).
Summary and ﬁnal thoughts
There have been some major advances in our understand-
ing of the impact of nutrition on brain function and the
aetiology and treatment of these disorders. Future break-
throughs are likely to combine nutritional genomics and
neuroscience with psychological and psychiatric research.
Due to the scale of the burden of mental, neurological and
substance-use disorders and the universality of food as a
modiﬁable risk factor, even small improvements in the
nutritional environment may translate to large gains in
mental health and wellbeing at a population level.
Substantial research progress is being made in this ﬁeld
and the contemporary research outlining the evidence in
relation to whole dietary interventions, nutraceuticals,
alcohol use and putative mechanisms of action is
presented in the present issue of Proceedings of the
Nutritional Society in the form of a series of review papers
authored by the speakers of the 2016 Nutrition Society
Winter Meeting. However, future advancement is contin-
gent upon appropriate investment and concerted action by
mental health advocates, funding bodies, and policy
makers, and the inclusion and recognition of the role of
nutrition at the level of policymaking.
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